Violich Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Violich Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,650	Closed	-$1.23M	–	106
2023 Q3	$1.23M	Hold	10,650	–	–	0.21%	54
2023 Q2	$1.09M	Hold	10,650	–	–	0.18%	60
2023 Q1	$1.16M	Hold	10,650	–	–	0.2%	59
2022 Q4	$1.21M	Hold	10,650	–	–	0.22%	57
2022 Q3	$659K	Hold	10,650	–	–	0.12%	69
2022 Q2	$849K	Hold	10,650	–	–	0.15%	63
2022 Q1	$1.12M	Sell	10,650 -100	-0.9%	-$9.74K	0.17%	61
2021 Q4	$1.16M	Hold	10,750	–	–	0.17%	63
2021 Q3	$1.18M	Hold	10,750	–	–	0.19%	61
2021 Q2	$1.01M	Hold	10,750	–	–	0.17%	62
2021 Q1	$989K	Sell	10,750 -2,250	-17%	-$190K	0.18%	61
2020 Q4	$951K	Buy	13,000 +50	+0.4%	+$3.72K	0.18%	58
2020 Q3	$1.01M	Hold	12,950	–	–	0.21%	50
2020 Q2	$720K	Hold	12,950	–	–	0.16%	68
2020 Q1	$384K	Sell	12,950 -850	-6%	-$28.8K	0.1%	75
2019 Q4	$500K	Hold	13,800	–	–	0.11%	80
2019 Q3	$376K	Sell	13,800 -500	-3%	-$12.9K	0.09%	84
2019 Q2	$344K	Hold	14,300	–	–	0.08%	88
2019 Q1	$378K	Hold	14,300	–	–	0.1%	83
2018 Q4	$279K	Hold	14,300	–	–	0.08%	90
2018 Q3	$280K	Sell	14,300 -1,760	-11%	-$33.5K	0.06%	97
2018 Q2	$266K	Buy	+16,060	New	+$245K	0.07%	100

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Violich Capital Management's HZNP Position: Q4 2023 in Review

Violich Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 10,650 shares — an estimated $1.23M sold.

Violich Capital Management first reported a position in HZNP in Q2 2018 and held it in 22 quarters. The position peaked at $1.23M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Violich Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Violich Capital Management sold 10,650 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $1.23M.
Violich Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2018 and held it in 22 quarters.
Violich Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.23M in Q3 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Violich Capital Management's 13F filing for Q4 2023, filed 26 Jan 2024.